The drug continues to be reviewed for its safety and effectiveness as a result of these alleged severe side effects and potential legal issues
The FIGHT study showed that more vulnerable HF patients with severely reduced HRQoL and perhaps more advanced stages of the disease may require complex care planning to improve their health status rather than solely increasing glucose and fatty acid metabolism to enhance cardiac metabolism
Orforglipron fits seamlessly into existing prescribing workflows alongside metformin, SGLT2 inhibitors, and other oral metabolic agents
Saxenda should be injected into the thigh, abdomen, or upper arm
In order to get the GLP-1 weight loss drugs for $50 a month, patients will need to have optional Medicare Part D drug plans
or BMI 27 with prediabetes or specific cardiovascular conditions), be using the medication alongside structured nutrition and physical activity, and obtain prior authorization through their Part D plan